Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Intranasal administration of peptides has been shown effective due to the following factors [27]: Large surface area Permeable endothelial membrane Elimination of first-pass effect Good circulation Researchers who wish to administer the BPC-157 and TB-500 blend via a nasal spray are encouraged to take certain precautions to ensure delivery of maximum bioavailability: To optimize absorption: Wait up to one minute between sprays via the same nostril to prevent oversaturating the nasal membrane and thus losing peptide due to swallowing
Drucker, Habener, Holst)
This allows for easy dosing where 0.25mL of the solution contains 250mcg of BPC-157
Consequently, researchers use it to probe cell growth and differentiation, protein synthesis, and glucose-metabolism pathways in non-clinical models
